In the BioHarmony Drug Report Database
Atracurium
Tracrium (atracurium) is a small molecule pharmaceutical. Atracurium was first approved as Tracrium on 1983-11-23. It is known to target neuronal acetylcholine receptor subunit alpha-4, neuronal acetylcholine receptor subunit alpha-7, acetylcholine receptor subunit alpha, and neuronal acetylcholine receptor subunit alpha-3.
Trade Name
|
Tracrium |
|---|---|
Common Name
|
atracurium |
ChEMBL ID
|
CHEMBL1360 |
Indication
|
|
Drug Class
|
Quaternary ammonium derivatives: neuromuscular blocking agents |
Image (chem structure or protein)